Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy […]
Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy […]
